SynthesisPain management2025

Effectiveness and safety of anti-CGRP monoclonal antibodies for migraine in patients over 65 years: a systematic review.

Albert Muñoz-Vendrell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.